Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE:002773)

Market Cap	28.12B
Revenue (ttm)	4.67B
Net Income (ttm)	1.25B
Shares Out	921.32M
EPS (ttm)	1.36
PE Ratio	22.43
Forward PE	21.19
Dividend	0.60 (1.97%)
Ex-Dividend Date	Jun 6, 2025

Volume	4,927,614
Average Volume	6,426,654
Open	30.49
Previous Close	30.52
Day's Range	30.41 - 31.19
52-Week Range	18.41 - 47.37
Beta	0.18
RSI	39.27
Earnings Date	Apr 27, 2026

About SHE:002773

Chengdu Kanghong Pharmaceutical Group Co., Ltd engages in the research, development, manufacture, and distribution of medicine for ophthalmic, neuropsychiatric and other applications in China. It also develops a pipeline of clinical and pre-clinical programs for ophthalmology, CNS, oncology, and common disease. The company was founded in 1996 and is based in Chengdu, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1996
• Employees: 4,462
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002773

Financial Performance

In 2024, SHE:002773's revenue was 4.45 billion, an increase of 12.51% compared to the previous year's 3.96 billion. Earnings were 1.19 billion, an increase of 14.02%.